IL6 and infection: In the first phase, tissue damage or infection leads to the release of inflammatory mediators (e.g., histamine, prostaglandins, leukotrienes, tumor necrosis factor (TNF), interleukin-1 (IL-1), and interleukin-6 (IL-6)).